Bilateral Asymmetric Best Vitelliform Macular Dystrophy in Adulthood: Insights from Multimodal Imaging

Read full text
Authors: Boutayna Azarkan, Latifa Sbai, Zineb Hilali, Saad Benchekroun, Abdellah Amazouzi, S. Tachfouti, Lalla Ouafaa Cherkaoui
Cited by: 0

Abstract

Purpose: To report a case of bilateral asymmetric adult-onset Best vitelliform macular dystrophy (BVMD), emphasizing the role of multimodal imaging—including fundus autofluorescence (FAF), optical coherence tomography (OCT), and OCT angiography (OCTA)—in detecting retinal dysfunction and subclinical choroidal neovascularization (CNV), and discussing the importance of genetic testing and early intervention. Methods: A 34-year-old patient presenting with decreased vision underwent comprehensive ophthalmic examination, color fundus photography, FAF, OCT, and OCTA. Clinical features, imaging findings, and follow-up data were documented. Results: Asymmetric macular lesions were observed: a Stage IV vitelliruptive lesion in the right eye and a Stage III pseudohypopyon lesion in the left eye. FAF demonstrated central hypoautofluorescence with scattered hyperautofluorescent areas in the right eye and a heterogeneous semi-lunar pattern in the left eye. OCT revealed disruption of the outer retinal layers, with intraretinal fluid (IRF) in areas of RPE dysfunction. OCTA showed no evidence of active CNV at initial evaluation. The patient had no known family history of inherited retinal disease. Conclusion: Adult-onset BVMD can present asymmetrically with subtle progression. Multimodal imaging is essential for early detection of RPE dysfunction and subclinical CNV. Early identification of CNV and timely intravitreal anti-VEGF treatment, when necessary, can stabilize visual function. Genetic testing is recommended to guide diagnosis, counseling, and long-term management.

Fields of Study & Subjects

Retinal Diseases and Treatments Retinal Development and Disorders Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
International Journal of Medical and Pharmaceutical Case Reports
Volume
19
Issue
1
Pages
8–13
Publication date
13 January 2026
Language
EN